Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: PETER MORICI who wrote (298)	9/21/1999 8:32:00 AM
From: kendall harmon	Respond to of 413

LVCI full text of the Dow Jones article: By Desiree J. Hanford ST. LOUIS (Dow Jones)--Shares of Laser Vision Centers Inc. (LVCI) fell nearly 15% Monday, a tumble the company's Chairman and Chief Executive John J. Klobnak attributed to misguided fears over pricing pressures. Laser Vision's stock closed Monday at 15 1/2, down 2 5/8, on heavy trading of more than 3 million shares. Average daily trading is 648,200 shares. The company's stock dropped 11% on Friday to close at 18 1/8. Laser Vision provides excimer lasers and other related equipment and services to doctors to correct eyesight problems. Klobnak told Dow Jones Newswires that some investors seem to be concerned about pricing pressures that, at least at Laser Vision Centers, don't exist. Klobnak said that although a competitor reportedly cut its prices on laser procedures last month in two markets, that price cut has no effect on Laser Vision Centers. An analyst said last month that LCA-Vision Inc. (LCAV) lowered prices at key laser vision correction centers in Baltimore and Annapolis, Md. The analyst's report warned that the moves could send prices lower in other markets. LCA-Vision's stock closed at 5 on Monday, down 7%, or 3/8, on heavier-than-normal trading. The stock also closed down on Friday. Klobnak said Laser Vision doesn't set the price that a doctor charges for the laser procedure. He said the company has contracts with doctors for a set price and term, neither of which is influenced by how much a doctor charges patients for the procedure. "Pricing is really up to the doctors," he said. "If they decide to be competitive by lowering the price or if they decide to charge a premium, it's their decision. But we charge them the same either way." Analysts who follow Laser Vision Centers said they remain bullish on the company's outlook. A.G. Edwards & Sons analyst Greg Simpson said the company's business remains "extremely strong." He said doctors are committing to longer deals with Laser Vision, with many of them making three- to five-year commitments instead of two years. "There's nothing specific to the company going on here," Simpson said of the drop in Laser Vision's stock. Simpson said that because of the contracts doctors have with Laser Vision Centers, doctors and not the company will bear the brunt of any price declines for eye procedures. "This is a company that has a business model that protects it from that," he said. Advest Inc. analyst Theodore Huber agrees. He said a lot of the concerns about price declines in the industry are overblown. Huber also noted that Laser Vision gets much of its revenues from smaller cities where the company has a large market share. -Desiree J. Hanford; 314-588-8443; Desiree.Hanford@cor.dowjones.com (END) DOW JONES NEWS 09-20-99 05:34 PM Source: messages.yahoo.com